CME Inc logo

CME - CME Inc Share Price

$199.7 -5.1  -2.5%

Last Trade - 26/02/21

Sector
Financials
Size
Large Cap
Market Cap £51.46bn
Enterprise Value £52.71bn
Revenue £3.51bn
Position in Universe 164th / 6715
Bullish
Bearish
Unlock CME Revenue
Momentum
Relative Strength (%)
1m +10.5%
3m
6m
1yr
Volume Change (%)
10d / 3m
Price vs... (%)
52w High -9.82%
50d MA
200d MA
Growth & Value
12m Forecast Rolling Industry Market
Valuation (ttm) Industry Market
Margin of Safety
Qualifying GuruScreens
Financial Summary
Year End 31st Dec 2015 2016 2017 2018 2019 2020 2021E 2022E CAGR / Avg
3,327 3,595 3,645 4,309 4,868 4,884 4,834 5,164 +8.0%
+10.0 +22.6 +157.3 -51.0 +3.5 +1.9 +10.7 +8.07
PEG
Profitability
ROA
%
%
Cashflow
Dividends
Balance Sheet
NFA
m
FINANCIAL BRIEF: : For the fiscal year ended 31 December 2020, CMEGroup Inc revenues increased less than 1% to $4.88B. Netincome decreased 1% to $2.11B. Revenues reflect OtherRevenue increase of 9% to $440.8M, Market data andinformation services increase of 5% to $545.4M, alsoreflect Clearing and transaction fees decrease of 1% to$3.9B. Net income was partially offset by Investment Incomedecrease of 71% to $182.7M (income).
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Distress
Cautious
Safe
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Graphical History

Revenue

CME Revenue Unlock CME Revenue

Net Income

CME Net Income Unlock CME Revenue

Normalised EPS

CME Normalised EPS Unlock CME Revenue

PE Ratio Range

CME PE Ratio Range Unlock CME Revenue

Dividend Yield Range

CME Dividend Yield Range Unlock CME Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2021
31st Dec 2022
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2019 /  2020
CME EPS Forecasts Unlock CME Revenue
Profile Summary

CME Group Inc., through its exchanges, provides products across all asset classes, including futures and options based on interest rates, equity indexes, foreign exchange, energy, agricultural products and metals. The Company's segment primarily consists of the Chicago Mercantile Exchange Inc. (CME), Board of Trade of the City of Chicago, Inc. (CBOT), New York Mercantile Exchange, Inc. (NYMEX) and Commodity Exchange, Inc. (COMEX) exchanges. The Company provides electronic trading around the globe on its CME Globex platform. The Company also offers clearing and settlement services across asset classes for exchange-traded and over-the-counter derivatives through its clearinghouses CME Clearing and CME Clearing Europe. It also provides hosting, connectivity and customer support for electronic trading through its co-location services. The Company's CME Direct platform offers side-by-side trading of exchange-listed and privately negotiated markets.

Directors
Last Annual December 31st, 2020
Last Interim December 31st, 2020
Incorporated August 2, 2001
Public Since December 6, 2002
No. of Shareholders: n/a
No. of Employees: 4,360
Sector Financials
Industry Investment Banking & Investment Services
Index Nasdaq Composite , S&P Composite 1500 , S&P 500 Financial (sector), S&P 500 ,
Exchange NASDAQ Global Select Market
Shares in Issue 358,990,597
Free Float (0.0%)
Eligible for
ISAs
SIPPs
CME Share Price Performance
Share Price
Bid - Ask
Low - High
Spread
Day's Change
Avg Volume
Open - Close
Range (12m)
Beta
Latest News for CME
Upcoming Events for CME
Tuesday 27th April, 2021 Estimate
Q1 2021 CME Group Inc Earnings Release
Frequently Asked Questions for CME Inc
What is the CME Inc share price?

As of 26/02/21, shares in CME Inc are trading at $199.7, giving the company a market capitalisation of £51.46bn. This share price information is delayed by 15 minutes.

How has the CME Inc share price performed this year?

Shares in CME Inc are currently trading at $199.7 and the price has moved by -3.75% over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the CME Inc price has moved by -25.74% over the past year.

What are the analyst and broker recommendations for CME Inc?

Of the analysts with advisory recommendations for CME Inc, there are there are currently 3 "buy" , 9 "hold" and 0 "sell" recommendations. The overall consensus recommendation for CME Inc is Hold. You can view the full broker recommendation list by unlocking its StockReport.

When will CME Inc next release its financial results?

CME Inc is scheduled to issue upcoming financial results on the following dates:

Interim results are scheduled for: 2021-12-31
What is the CME Inc dividend yield?

The CME Inc dividend yield is 1.7% based on the trailing twelve month period.

Does CME Inc pay a dividend?

Last year, CME Inc paid a total dividend of 3.4, and it currently has a trailing dividend yield of 1.7%. Looking ahead, shares in CME Inc are due to go ex-dividend on 2021-03-09 and the next dividend pay date is 2021-03-25.

When does CME Inc next pay dividends?

CME Inc are due to go ex-dividend on 2021-03-09 and the next dividend pay date is 2021-03-25. The historic dividend yield on CME Inc shares is currently 1.7%.

How do I buy CME Inc shares?

To buy shares in CME Inc you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.

What is the market cap of CME Inc?

Shares in CME Inc are currently trading at $199.7, giving the company a market capitalisation of £51.46bn.

Where are CME Inc shares listed? Where are CME Inc shares listed?

Here are the trading details for CME Inc:

Country of listing: United States
Exchange: NSQ
Ticker Symbol: CME
What kind of share is CME Inc?

Based on an overall assessment of its quality, value and momentum, CME Inc is currently classified as a Style Neutral. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.

Is there a CME Inc share price forecast 2021?

Shares in CME Inc are currently priced at $199.7. At that level they are trading at 4.09% premium to the analyst consensus target price of 0.00.

Analysts covering CME Inc currently have a consensus Earnings Per Share (EPS) forecast of 6.667 for the next financial year.

How can I tell whether the CME Inc share price will go up?

An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like CME Inc. Over the past six months, the relative strength of its shares against the market has been 4.56%. At the current price of $199.7, shares in CME Inc are trading at 15.39% against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.

What is the CME Inc PE Ratio?

The CME Inc PE ratio based on its reported earnings over the past 12 months is 33.17. The shares are currently trading at $199.7.

The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.

The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.

Who are the key directors of CME Inc?

CME Inc's management team is headed by:

Terrence Duffy - CHM
Daniel Glickman - LED
Dennis Chookaszian - IND
Kathleen Cronin - GCN
Julie Holzrichter - SMD
Charles Carey - VCH
Hilda Piell - CHO
Timothy Bitsberger - IND
Kevin Kometer - CIO
John Pietrowhicz - CFO
Derek Sammann - SMD
Sunil Cutinho - CEX
Jack Tobin - CAO
Elizabeth Cook - IND
Michael Spencer - DRC
Who are the major shareholders of CME Inc?

Here are the top five shareholders of CME Inc based on the size of their shareholding:

Capital World Investors Investment Advisor
Percentage owned: 9.43% (33.8m shares)
The Vanguard Group, Inc. Investment Advisor/Hedge Fund
Percentage owned: 7.86% (28.2m shares)
State Street Global Advisors (US) Investment Advisor/Hedge Fund
Percentage owned: 4.59% (16.5m shares)
BlackRock Institutional Trust Company, N.A. Investment Advisor
Percentage owned: 4.52% (16.2m shares)
American Funds Washington Mutual Investors Fund Mutual Fund
Percentage owned: 3.91% (14.0m shares)
Similar to CME
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.